FDA
- Marketing authorisation holder: CHESEBROUGH PONDS
- Status: approved
Lapyrium (LAPYRIUM CHLORIDE) regulatory status in United States.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA has authorised it.
CHESEBROUGH PONDS holds the US marketing authorisation.